Tactile Systems Technology Inc (TCMD) reports a robust 17% revenue increase and raises full-year guidance, despite challenges ...

Q3 2025 Management View CEO Sheri Dodd opened by highlighting "progress in both strategy and operational execution, demonstrated by meaningful advances in business transformation, product innovation ...

Operating expenses in the third quarter of 2025 increased $6.0 million, or 13%, to $54.0 million, compared to $48.0 million in the third quarter of 2024. Operating income was $11.0 million in the ...

Arm lymphedema is a common and sometimes challenging side effect that can occur after breast cancer treatment, causing ...

The new long-term results follow two-month data released at ASCO in June 2025 and are drawn from the largest prospective, randomized controlled study ever conducted among head and neck cancer ...

Technical Consumer Products (TCP), a lighting manufacturer, sued former regional sales manager Patrick Heckman and EIKO Global on Oct. 14 in Ohio Court of Common Pleas for Portage County over alleged ...

LAKE FOREST, Ill., October 15, 2025--(BUSINESS WIRE)--Reynolds Consumer Products Inc. (Nasdaq: REYN) (the "Company") announced it will report third quarter financial results on Wednesday, October 29, ...

Scrotal lymphedema occurs when you have a blockage in the lymphatic vessels in your scrotum. Your scrotum is the sac beneath your penis that holds your testicles, which make sperm. Scrotal lymphedema ...

This powerful serum taps the power of proxylane, a synethetic sugar derivative that mimics the effects of the natural sugars ...

Patients who have been treated at Fred Hutch Cancer Center can be seen in the Physical Therapy department by one of our Certified Lymphedema Therapists, who are trained in teaching patients how to ...

About Mueller Water Products Inc. Mueller Water Products, Inc. engages in the manufacture and sale of products used in the transmission, distribution, and measurement of water. It operates through the ...

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...